Target Binding Site Detail
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T60631 | Target Info | |||
| Target Name | Proto-oncogene c-Ret (RET) | ||||
| Synonyms | RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; Proto-oncogene tyrosine-protein kinase receptor Ret; PTC; Cadherin family member 12; CDHR16; CDHF12; C-ret | ||||
| Target Type | Successful Target | ||||
| Gene Name | RET | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Ligand General Information | Top | ||||
|---|---|---|---|---|---|
| Ligand Name | Adenosine | Ligand Info | |||
| Canonical SMILES | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N | ||||
| InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | ||||
| InChIKey | OIRDTQYFTABQOQ-KQYNXXCUSA-N | ||||
| PubChem Compound ID | 60961 | ||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| PDB ID: 4CKJ Crystal structure of RET tyrosine kinase domain bound to adenosine | ||||||
| Method | X-ray diffraction | Resolution | 1.65 Å | Mutation | No | [1] |
| PDB Sequence |
GPLSLSVDAF
709 KILEDPKWEF719 PRKNLVLGKT729 LGEGEFGKVV739 KATAFHLKGR749 AGYTTVAVKM 759 LKENASPSEL769 RDLLSEFNVL779 KQVNHPHVIK789 LYGACSQDGP799 LLLIVEYAKY 809 GSLRGFLRES819 RKVRALTMGD850 LISFAWQISQ860 GMQYLAEMKL870 VHRDLAARNI 880 LVAEGRKMKI890 SDFGLSRDVY900 EEDSVKRSQG911 RIPVKWMAIE921 SLFDHIYTTQ 931 SDVWSFGVLL941 WEIVTLGGNP951 YPGIPPERLF961 NLLKTGHRME971 RPDNCSEEMY 981 RLMLQCWKQE991 PDKRPVFADI1001 SKDLEKMMVK1011 RR
|
|||||
|
|
||||||
| PDB ID: 4CKI Crystal Structure of oncogenic RET tyrosine kinase M918T bound to adenosine | ||||||
| Method | X-ray diffraction | Resolution | 2.12 Å | Mutation | Yes | [1] |
| PDB Sequence |
GPLSLSVDAF
709 KILEDPKWEF719 PRKNLVLGKT729 LGEGEFGKVV739 KATAFHLKGR749 AGYTTVAVKM 759 LKENASPSEL769 RDLLSEFNVL779 KQVNHPHVIK789 LYGACSQDGP799 LLLIVEYAKY 809 GSLRGFLRES819 RKVDERALTM848 GDLISFAWQI858 SQGMQYLAEM868 KLVHRDLAAR 878 NILVAEGRKM888 KISDFGLSRD898 VEEDSVKRSQ910 GRIPVKWTAI920 ESLFDHIYTT 930 QSDVWSFGVL940 LWEIVTLGGN950 PYPGIPPERL960 FNLLKTGHRM970 ERPDNCSEEM 980 YRLMLQCWKQ990 EPDKRPVFAD1000 ISKDLEKMMV1010 KRR
|
|||||
|
|
||||||
| PDB ID: 6FEK Oncogenic point mutation of RET receptor tyrosine kinase | ||||||
| Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | Yes | [2] |
| PDB Sequence |
GPLSLSVDAF
709 KILAAPKWEF719 PRKNLVLGKT729 LGEGEFGKVV739 KATAFHLKGR749 AGYTTVAVKM 759 LKENASPSEL769 RDLLSEFNVL779 KQVNHPHVIK789 LYGACSQDGP799 LLLIVEYAKY 809 GSLRGFLRES819 RKVGPGPDER844 ALTMGDLISF854 AWQISQGMQY864 LAEMKLVHRD 874 LAARNILVAE884 GRKMKISDFG894 LSRDVEEDFV906 KRSQGRIPVK916 WMAIESLFDH 926 IYTTQSDVWS936 FGVLLWEIVT946 LGGNPYPGIP956 PERLFNLLKT966 GHRMERPDNC 976 SEEMYRLMLQ986 CWKQEPDKRP996 VFADISKDLE1006 KMMV
|
|||||
|
|
LEU730
2.806
GLY731
2.971
GLU732
4.142
GLY733
3.476
GLY736
4.823
LYS737
4.834
VAL738
2.428
ALA756
2.936
LYS758
3.648
ILE788
2.899
VAL804
2.632
|
|||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans. Mol Cell. 2014 Mar 6;53(5):738-51. | ||||
| REF 2 | A secondary RET mutation in the activation loop conferring resistance to vandetanib. Nat Commun. 2018 Feb 12;9(1):625. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.